| Application no. and date | 17835212.6 (espacenet) (Federated) (European Patent Register), 20170726 | | Patent/reg. no. and date | DK/EP 3490582, 20240612 | | Publication date | 20190605 | | Priority no. and date | US 201662367289 P, 20160727 | | EP pub. no. and date |
EP 3490582 20190605 | | Effective date | | | Applicant/owner | Acceleron Pharma Inc., 128 Sidney Street
Cambridge, MA 02139, US | | Applicant ref. no. | 166686 | | Inventor | KUMAR, Ravindra, 421 Arlington Street
Acton, MA 01720, US,
VENKATA SAI RAJASEKHAR SURAGANI, Naga, 85 Black Birch Drive
Wrentham, MA 02093, US | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/519 (2006.01) , A61K 38/17 (2006.01) , A61K 45/06 (2006.01) , A61K 47/68 (2017.01) , A61P 7/00 (2006.01) , A61P 7/06 (2006.01) , C07K 14/71 (2006.01) | | Title | SAMMENSÆTNINGER TIL ANVENDELSE I BEHANDLING AF MYELOFIBROSE | | Int. application no. | US2017043967 | | Int. publication no. | WO2018022762 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
